$4.21
-0.03-0.59%
Comments
Loading...
Iovance Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:IOVA | Benzinga
Iovance Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.220
Quarterly Revenue Estimate
$88.59M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$164.07M
Analyze the earnings history of Iovance Biotherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Iovance Biotherapeutics (IOVA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.26 | $-0.27 | 3.70 % |
| Q3 | 2024-11-07 | $-0.28 | $-0.30 | 6.67 % |
| Q2 | 2024-08-08 | $-0.34 | $-0.35 | 2.86 % |
| Q1 | 2024-05-09 | $-0.42 | $-0.42 | 0.00 % |
Iovance Biotherapeutics (IOVA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $73.69M | $72.17M | 2.11 % |
| Q3 | 2024-11-07 | $58.56M | $53.81M | 8.82 % |
| Q2 | 2024-08-08 | $31.11M | $27.07M | 14.9 % |
| Q1 | 2024-05-09 | $715.00K | $2.07M | -65.5 % |
FAQ
When is Iovance Biotherapeutics (NASDAQ:IOVA) reporting earnings?
Iovance Biotherapeutics (IOVA) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Iovance Biotherapeutics (NASDAQ:IOVA)?
The Actual EPS was $-0.26, which beat the estimate of $-0.27.
What were Iovance Biotherapeutics’s (NASDAQ:IOVA) revenues?
The Actual Revenue was $73.7M, which beat the estimate of $72.2M.
Browse earnings estimates, EPS, and revenue on all stocks.